{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:36:40Z","timestamp":1753738600623,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10096-019-03643-7","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T07:03:36Z","timestamp":1564383816000},"page":"2097-2102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection"],"prefix":"10.1007","volume":"38","author":[{"given":"Elsa","family":"Roldan-Masedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Gutierrez-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Gomez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefania","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Escosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Baquero-Artigao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7455-9080","authenticated-orcid":false,"given":"Ana","family":"M\u00e9ndez-Echevarr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"3643_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.anpedi.2011.10.002","volume":"76","author":"CC de Lucas","year":"2012","unstructured":"de Lucas CC, Cela Alvargonzalez J, Angulo Chac\u00f3n A, Garc\u00eda Ascaso M, Pi\u00f1eiro P\u00e9rez R, Cilleruelo Ortega M, S\u00e1nchez Romero I (2012) Urinary tract infections: antibiotic resistance and clinical follow up. An Pediatr\u00eda (Barc) 76:224\u2013228","journal-title":"An Pediatr\u00eda (Barc)"},{"key":"3643_CR2","first-page":"31","volume":"8","author":"J Ramlakhan Stone","year":"2014","unstructured":"Ramlakhan Stone J, Singh V, Ramtahal A (2014) Clinical options for the treatment of urinary tract infections in children. Clin Med Insights Pediatr 8:31\u201337","journal-title":"Clin Med Insights Pediatr"},{"issue":"37","key":"3643_CR3","doi-asserted-by":"publisher","first-page":"e7834","DOI":"10.1097\/MD.0000000000007834","volume":"96","author":"G Pouladfar","year":"2017","unstructured":"Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S (2017) The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine (Baltimore) 96(37):e7834","journal-title":"Medicine (Baltimore)"},{"key":"3643_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.eimc.2016.01.012","volume":"35","author":"R Hern\u00e1ndez Marco","year":"2017","unstructured":"Hern\u00e1ndez Marco R, Guill\u00e9n Olmos E, Bret\u00f3n-Mart\u00ednez J, Giner P\u00e9rez L, Casado S\u00e1nchez B, Fujkova J, Salamanca Campos M, Nogueira Coito J (2017) Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants. Enferm Infecc Microbiol Clin 35:287\u2013292","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3643_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/IDR.S148703","volume":"10","author":"M Polat","year":"2017","unstructured":"Polat M, Kara SS (2017) Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in children. Infect Drug Resist 10:393\u2013399","journal-title":"Infect Drug Resist"},{"key":"3643_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/apa.13656","volume":"106","author":"O Nieminen","year":"2017","unstructured":"Nieminen O, Korppi M, Helminen M (2017) Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing bacteria. Acta Paediatr 106:327\u2013333","journal-title":"Acta Paediatr"},{"key":"3643_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jpeds.2013.06.078","volume":"163","author":"N Dayan","year":"2013","unstructured":"Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013) Urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163:1417\u20131421","journal-title":"J Pediatr"},{"key":"3643_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1442-200X.2012.03709.x","volume":"54","author":"O Kizilca","year":"2012","unstructured":"Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, Ozkok D (2012) Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 54:858\u2013862","journal-title":"Pediatr Int"},{"key":"3643_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jped.2016.06.009","volume":"93","author":"YH Kim","year":"2017","unstructured":"Kim YH, Yang EM, Kim CJ (2017) Urinary tract infection caused by community-acquired extended-spectrum \u03b2-lactamase-producing bacteria in infants. J Pediatr 93:260\u2013266","journal-title":"J Pediatr"},{"key":"3643_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/0974-2727.208262","volume":"9","author":"SA Veena","year":"2017","unstructured":"Veena SA, Rathika SD, Vijaya SM, Avinash SK (2017) Antimicrobial susceptibility, risk factors and prevalence of bla cefotaximase, temoneira, and sulfhydryl variable genes among Escherichia coli in community-acquired pediatric urinary tract infection. J Lab Physicians 9:156\u2013152","journal-title":"J Lab Physicians"},{"key":"3643_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/ped.13112","volume":"59","author":"N Uyar Aksu","year":"2017","unstructured":"Uyar Aksu N, Ekinci Z, D\u00fcndar D, Baydemir C (2017) Childhood urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing bacteria: risk factors and empiric therapy. Pediatr Int 59:176\u2013180","journal-title":"Pediatr Int"},{"key":"3643_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.eimc.2016.11.001","volume":"35","author":"D Salas-Mera","year":"2017","unstructured":"Salas-Mera D, Sainz T, G\u00f3mez-Gil Mira M, M\u00e9ndez-Echevarr\u00eda A (2017) Gentamicin resistance E. coli as a cause of urinary tract infections in children. Enferm Infecc Microbiol Clin 35:465\u2013466","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3643_CR13","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.1, 2016. \n                    http:\/\/www.eucast.org\n                    \n                  . Accessed 8 July 2019"},{"key":"3643_CR14","doi-asserted-by":"publisher","first-page":"e1606","DOI":"10.1097\/MD.0000000000001606","volume":"94","author":"M Rezaee","year":"2015","unstructured":"Rezaee M, Abdinia B (2015) Etiology and antimicrobial susceptibility pattern of pathogenic bacteria in children subjected to UTI. Medicine. 94:e1606","journal-title":"Medicine."},{"key":"3643_CR15","doi-asserted-by":"publisher","unstructured":"Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, Sayami S et al (2017) High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control. \n                    https:\/\/doi.org\/10.1186\/s13756-016-0168-6","DOI":"10.1186\/s13756-016-0168-6"},{"key":"3643_CR16","doi-asserted-by":"publisher","first-page":"e0190910","DOI":"10.1371\/journal.pone.0190910","volume":"13","author":"F Madhi","year":"2018","unstructured":"Madhi F, Jung C, Timsit S, Levy C, Biscardi S, Lorrot M et al (2018) Febrile urination-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a French prospective multicenter study. PLoS One 13:e0190910","journal-title":"PLoS One"},{"key":"3643_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpeds.2015.12.044","volume":"171","author":"N Shaikh","year":"2016","unstructured":"Shaikh N, Hoberman A, Keren R, Ivanova A, Gotman N, Chesney R, Carpenter M, Moxey-Mims M, Wald E (2016) Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. J Pediatr 171:116\u2013121","journal-title":"J Pediatr"},{"key":"3643_CR18","doi-asserted-by":"crossref","unstructured":"Selekman RE, Shapiro DJ, Boscardin J, Williams G, Craig JC, Brandstr\u00f6m P et al (2018) Uropathogen resistance and antibiotic prophylaxis: a meta-analysis. Pediatrics 142 (1)","DOI":"10.1542\/peds.2018-0119"},{"key":"3643_CR19","first-page":"332","volume":"6","author":"CS Forster","year":"2017","unstructured":"Forster CS, Courter J, Jackson EC, Mortensen JE, Haslam DB (2017) Frequency of multidrug-resistant organisms cultured from urine of children undergoing clean intermittent catheterization. J Pediatric Infect Dis Soc 6:332\u2013338","journal-title":"J Pediatric Infect Dis Soc"},{"key":"3643_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jiph.2015.10.002","volume":"9","author":"M Mishra","year":"2016","unstructured":"Mishra M, Sarangi R, Padhy R (2016) Prevalence of multidrug resistant uropathogenic bacteria in pediatric patients of a tertiary care hospital in eastern India. J Infect Public Health 9:308\u2013314","journal-title":"J Infect Public Health"},{"key":"3643_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12879-015-1153-z","volume":"15","author":"S Han","year":"2015","unstructured":"Han S, Lee S, Lee S, Jeong D, Kang J (2015) Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae. BMC Infect Dis 15:414","journal-title":"BMC Infect Dis"},{"key":"3643_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/INF.0000000000001373","volume":"36","author":"R Yakubov","year":"2017","unstructured":"Yakubov R, van den Akker M, Machamad K, Hochberg A, Nadir E, Klein A (2017) Antimicrobial resistance among uropathogens that cause childhood community-acquired urinary tract infections in Central Israel. Pediatr Infect Dis J 36:113\u2013115","journal-title":"Pediatr Infect Dis J"},{"key":"3643_CR23","first-page":"571","volume":"55","author":"J Dotis","year":"2013","unstructured":"Dotis J, Printza N, Marneri A, Gidaris D, Papachristou F (2013) Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched case control study. Turk J Pediatr 55:571\u2013574","journal-title":"Turk J Pediatr"},{"key":"3643_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijantimicag.2006.08.009","volume":"28","author":"S Y\u00fcksel","year":"2006","unstructured":"Y\u00fcksel S, \u00d6zt\u00fcrk B, Kavaz A, \u00d6z\u00e7akar Z, Acar B, G\u00fcriz H, Aysev D, Ekim M, Yal\u00e7\u0131nkaya F (2006) Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 28:413\u2013416","journal-title":"Int J Antimicrob Agents"},{"key":"3643_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jiac.2017.04.006","volume":"23","author":"Y Abe","year":"2017","unstructured":"Abe Y, Inan-Erdogan I, Fukuchi K, Wakabayashi H, Ogawa Y, Hibino S et al (2017) Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli. J Infect Chemother 23:517\u2013522","journal-title":"J Infect Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03643-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:26:20Z","timestamp":1595892380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03643-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3643"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03643-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. The study protocol was approved by the La Paz Hospital\u2019s Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}